Secondary Outcomes
pain
A significant main treatment effect of VR was seen on the daily worst experienced pain score (Mean and standard error of the mean of daily worst VAS pain score (A) and daily least VAS pain score (B) during the intervention period. In the intervention group, data were missing for 1 patient from day 8, for 1 patient from day 12, for 1 patient from day 13, for 2 patients from day 25, for 1 patient from day 26, and for 1 patient from day 27. VAS indicates visual analog scale.Number (%) of Participants Reported Have Used Analgesics at Least Once in Week 1 and in Week 4NSAID indicates nonsteroidal anti-inflammatory drug.